SCHEMBL4047080

SCHEMBL4047080

CCS(=O)(=O)c1ccc2nc(-c3ccc(Cl)cc3)oc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.56
POLB P06746 3/20 0.56
TP53 P04637 3/20 0.56
MAPT P10636 3/20 0.56
UTRN P46939 4/20 0.56
CYP1A2 P05177 1/20 0.56
AHR P35869 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
PTPN2 P17706 3/20 0.52
PTPN1 P18031 3/20 0.52
PTPN5 P54829 3/20 0.52
HSPD1 P10809 2/20 0.52
HSPE1 P61604 2/20 0.52
GPR119 Q8TDV5 2/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
MAOB P27338 1/20 0.47
SLC47A1 Q96FL8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2243999 0.90 UTRN (0.70) LMNAPOLBMAPTUTRNCYP1A2
SCHEMBL3949747 0.87 UTRN (0.57) LMNAPOLBTP53MAPTUTRN
SCHEMBL27652467 0.86 MAPT (0.58) LMNAPOLBTP53MAPTPTPN2
SCHEMBL26686674 0.85 TP53 (0.56) LMNATP53MAPTUTRNCYP1A2
SCHEMBL2244328 0.85 UTRN (0.60) LMNAPOLBMAPTUTRNCYP1A2
SCHEMBL19664251 0.85 UTRN (0.54) LMNAPOLBTP53MAPTUTRN
SCHEMBL2245432 0.81 UTRN (0.59) LMNAPOLBMAPTUTRNCYP1A2
SCHEMBL10590678 0.78 SMN1; SMN2 (0.61) LMNAPOLBTP53MAPTGPR119
SCHEMBL2244375 0.77 UTRN (0.71) LMNAPOLBTP53MAPTUTRN
SCHEMBL2247922 0.77 UTRN (0.70) POLBMAPTUTRNCYP1A2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009021750-A2 TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2009-02-19 WO disclosed